Home » Newsletters » BioWorld Science

BioWorld Science

April 5, 2006

View Archived Issues

Merck & Co. licenses know how from Atugen

Phenoxodiol active in women with chemotherapy-resistant ovarian cancer

Lipocine completes product definition study on LPCN-1029

Millenia Hope advances programs in malaria and HIV/AIDS

Gen-Probe submits BLA amendment for Procleix Ultrio assay

Duke University to study bird flu vaccine dosing

BioSante profiles recent highlights

BioInvent and Immusol collaborate on antibody therapeutics for AMD

CF-101 to begin trial in dry eye symptoms, subject of MOU for Japan

Bioniche cleared for second phase III bladder cancer study of MCC

GSK and Sirna form RNAi strategic alliance in respiratory diseases

Pharmacopeia licenses DARA compounds from Bristol-Myers Squibb

Amgen completes acquisition of Abgenix

MediGene grants licenses to Virionics for CVLP vaccine program

Negative alpha-HGA results lead Tripep to refocus on ChronVac-C

Wyeth presents new orally active progesterone receptor antagonist

Aegera Therapeutics presents new BIR-binding XIAP antagonists for cancer

Histamine dihydrochloride, interleukin-2 beneficial in acute myeloid leukemia

Therapeutic agents for HIV infection disclosed in recent patent literature

New Astellas patent imparts novel treatment option for macular edema

CV Therapeutics and Actelion disclose novel agents for cardiovascular diseases

Sopherion designs potent mechanism-based antiangiogenic antitumor agents

Phase I study results for Conforma's ansamycin compound described at AACR meeting

Reata presents favorable preclinical data for RTA-502

Priority review granted to Neurodex NDA in emotional lability

Remicade sBLA for pediatric Crohn's disease granted priority review

SC-2-71: a thalidomide analogue with antiangiogenic and proapoptotic effects

Antiangiogenic AdNectin compound heading for clinical trials

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 20, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...